By Caroline Copley ZURICH (Reuters) - Swiss drugmaker Roche hopes data published this week will show it has a viable follow-on product to help fend off cheaper competition for its best-selling cancer drug, which loses patent protection in Europe l... More »
TRENTON, N.J. (AP) — Two multinational drugmakers are teaming up with top global health groups to protect millions of girls in the world's poorest countries from deadly cervical cancer. More »
By David Lawder WASHINGTON (Reuters) - As Congress sifts through a growing number of requests for targeted relief from automatic spending cuts in coming weeks, advocates seeking funding shifts likely will need to tell a compelling story with poten... More »
By Asher Levine SAO PAULO (Reuters) - Latin America's growing prosperity is fueling a cancer epidemic that threatens to overwhelm the region unless governments take urgent preventive action, a study published on Friday warned. A multinational ... More »
By Genevra Pittman NEW YORK (Reuters Health) - Doctors should talk about breast cancer-reducing drugs with women and offer tamoxifen or raloxifene to those that have a high risk of cancer and aren't likely to suffer side effects, a government-... More »
(Reuters) - Merrimack Pharmaceuticals Inc said one of three patient groups in a mid-stage trial of its experimental lung cancer drug failed to meet the main goal of improving survival rates after four months of treatment without the disease worsen... More »
(Reuters) - Amgen Inc said its experimental and novel treatment for advanced melanoma met the main goal of a late-stage clinical trial by demonstrating a durable response in significantly more patients than a comparison treatment. The drug known a... More »
By Ransdell Pierson (Reuters) - The Food and Drug Administration is studying unconfirmed reports that a widely used class of diabetes drugs, which includes Merck & Co's Januvia, may cause inflammation of the pancreas and pre-cancerous changes ... More »
CARACAS (Reuters) - President Hugo Chavez died on Tuesday after a two-year battle with cancer, ending 14 years of tumultuous and divisive rule that won him passionate support among the poor but hatred from business leaders and wealthy Venezuelans.... More »
CARACAS (Reuters) - Venezuela's political and military leaders gathered at the presidential palace and supporters wept on Tuesday after the government said President Hugo Chavez had suffered a serious setback in his battle against cancer. &quo... More »